Physician profile
Allison A Lambert
NPI 1649439209
$1,205.00
in general payments reported to CMS, 2019-2025
15 companies · $329 in 2025
The $329 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $33.75 · 2020: $36.13 · 2021: $99.00 · 2022: $203 · 2023: $356 · 2024: $149 · 2025: $329.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $833.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $833.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $249.98 | 2024-2025 | Dupixent |
| Chiesi USA, INC. | $181.64 | 2022 | |
| Pulmonx Corporation | $144.66 | 2023 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Chartis Catheter |
| Baxter Healthcare | $128.89 | 2023-2025 | Hillrom - Volara System, Hillrom - Vest System Model 105 Home Care, Hillrom - Synclara Cough System |
| Insmed, INC. | $117.87 | 2020-2021 | |
| Vertex Pharmaceuticals Incorporated | $116.53 | 2019-2025 | |
| Electromed, INC. | $77.19 | 2023 | Smartvest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $64.82 | 2025 | |
| Abbott Laboratories | $48.66 | 2023 | Freestyle Libre 3 |
| Genzyme Corporation | $23.76 | 2024 | |
| Philips North America LLC | $21.04 | 2022 | |
| Allergan, INC. | $17.26 | 2020 | |
| Merck Sharp & Dohme LLC | $12.70 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Lambert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.